Abstract
Recent studies suggest that lipocalin-type prostaglandin (PG) D synthase (L-PGDS), which converts PGH2 to PGD2, is implicated in the pathogenesis of atherosclerosis. However, clinical evidence for the association between serum L-PGDS levels and atherosclerosis has not been reported. In this study, we measured the serum L-PGDS concentration using sandwich enzyme-linked immunosorbent assay (ELISA) and investigated the association with traditional cardiovascular risk factors and surrogate atherosclerotic indices, such as the maximum score of the intima-media complex thickness of the carotid artery (C-IMTmax) and the brachial-ankle pulse wave velocity (ba-PWV), in 500 non-treated asymptomatic subjects. The serum concentration of L-PGDS was 0.56±0.01 (mean±SEM, range 0.25−1.27, median 0.54) mg/L. Serum L-PGDS levels increased with age and were higher in men than in women. Serum L-PGDS was higher in subjects with hypertension and increased with increasing numbers of the traditional atherosclerotic risk factors. When the subjects were divided into four groups according to the levels of serum L-PGDS, the age-adjusted values of C-IMTmax and ba-PWV were significantly increased in subjects with higher serum L-PGDS levels (quartile 3 and quartile 4) compared to those in the lowest quartile (quartile 1), for both genders. Multiple regression analysis including risk factors revealed that serum L-PGDS was an independent determinant for ba-PWV (β=0.130, p<0.001). Serum L-PGDS tended to associate with C-IMTmax but was not statistically significant (β=0.084, p=0.075). In conclusion, our results suggest that an increase in serum L-PGDS concentration is associated with the progression of atherosclerosis.
Similar content being viewed by others
Article PDF
References
Eguchi Y, Eguchi N, Oda H, et al: Expression of lipocalintype prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci U S A 1997; 94: 14689–14694.
Taba Y, Sasaguri T, Miyagi M, et al: Fluid shear stress induces lipocalin-type prostaglandin D2 synthase expression in vascular endothelial cells. Circ Res 2000; 86: 967–973.
Ragolia L, Palaia T, Koutrouby TB, Maesaka JK : Inhibition of cell cycle progression and migration of vascular smooth muscle cells by prostaglandin D2 synthase: resistance in diabetic Goto-Kakizaki rats. Am J Physiol Cell Physiol 2004; 287: C1273–C1281.
Cipollone F, Fazia M, Iezzi A, et al: Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 2004; 24: 1259–1265.
Ragolia L, Palaia T, Hall CE, Maesaka JK, Eguchi N, Urade Y : Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J Biol Chem 2005; 280: 29946–29955.
Bushfield M, McNicol A, MacIntyre DE : Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. Biochem J 1985; 232: 267–271.
Negishi M, Sugimoto Y, Ichikawa A : Prostanoid receptors and their biological actions. Prog Lipid Res 1993; 32: 417–434.
Nagoshi H, Uehara Y, Kanai F, et al: Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ Res 1998; 82: 204–209.
Negoro H, Soo Shin W, Hakamada-Taguchi R, et al: Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells. J Hypertens 2002; 20: 1347–1354.
Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK : The peroxisome proliferator.activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79–82.
Jiang C, Ting AT, Seed B : PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82–86.
Marx N, Sukhova G, Murphy C, Libby P, Plutzky J : Macrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator.activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. Am J Pathol 1998; 153: 17–23.
Sasaguri T, Masuda J, Shimokado K, et al: Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. Exp Cell Res 1992; 200: 351–357.
Miwa Y, Sasaguri T, Inoue H, Taba Y, Ishida A, Abumiya T : 15-Deoxy-Δ12.14-prostaglandin J2 induces G1 arrest and differentiation marker expression in vascular smooth muscle cells. Mol Pharmacol 2000; 58: 837–844.
Miwa Y, Takahashi-Yanaga F, Morimoto S, Sasaguri T : Involvement of clusterin in 15-deoxy-Δ12,14-prostaglandin J2–induced vascular smooth muscle cell differentiation. Biochem Biophys Res Commun 2004; 319: 163–168.
Hirawa N, Uehara Y, Yamakado M, et al: Lipocalin-type prostaglandin D synthase in essential hypertension. Hypertension 2002; 39: 449–454.
Inoue T, Takayanagi K, Morooka S, et al: Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. Thromb Haemost 2001; 85: 165–170.
Oda H, Shiina Y, Seiki K, Sato N, Eguchi N, Urade Y : Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. Clin Chem 2002; 48: 1445–1453.
Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M : Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res 2003; 26: 163–167.
Hirawa N, Uehara Y, Ikeda T, et al: Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus. Nephron 2001; 87: 321–327.
Hamano K, Totsuka Y, Ajima M, et al: Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients. Nephron 2002; 92: 77–85.
Taba Y, Miyagi M, Miwa Y, et al: 15-Deoxy-Δ12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells. Am J Physiol Heart Circ Physiol 2003; 285: H38–H46.
Miwa Y, Takiuchi S, Kamide K, et al: Identification of gene polymorphism in lipocalin-type prostaglandin D synthase and its association with carotid atherosclerosis in Japanese hypertensive patients. Biochem Biophys Res Commun 2004; 322: 428–433.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miwa, Y., Oda, H., Shiina, Y. et al. Association of Serum Lipocalin-Type Prostaglandin D Synthase Levels with Subclinical Atherosclerosis in Untreated Asymptomatic Subjects. Hypertens Res 31, 1931–1939 (2008). https://doi.org/10.1291/hypres.31.1931
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1931
Keywords
This article is cited by
-
An eicosanoid-centric view of atherothrombotic risk factors
Cellular and Molecular Life Sciences (2012)